$0.98
-0.03 (-2.92%)
Open$1.01
Previous Close$1.01
Day High$1.05
Day Low$0.96
52W High$2.35
52W Low$0.76
Volume—
Avg Volume797.0K
Market Cap133.44M
P/E Ratio—
EPS$-0.16
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,769.5% upside
Current
$0.98
$0.98
Target
$37.94
$37.94
$25.58
$37.94 avg
$45.71
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 60.16M | 53.18M | 50.95M |
| Net Income | -7,561,680 | -6,775,030 | -7,233,045 |
| Profit Margin | -12.6% | -12.7% | -14.2% |
| EBITDA | -8,587,792 | -7,436,735 | -8,070,839 |
| Free Cash Flow | -10,429,515 | -10,842,286 | -7,296,543 |
| Rev Growth | -4.1% | +12.5% | -5.7% |
| Debt/Equity | 1.23 | 1.43 | 1.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |